Managers / Q4 2019 · view latest →
M.D. Sass, LLC
CIK 0000922940 · 55 WEST 46TH STREET, SUITE 2801, NEW YORK, NY, 10036 · 2127302000
Reported Value
$859M
Q4 2019
Positions
100
Filings on Record
37
2019–present window
Filed
Jan 30, 2020
amendment (RESTATEMENT)
Summary
M.D. Sass, Llc reported $859M in U.S.-listed holdings across 100 positions for Q4 2019.
Its largest position, PHG, represents 2.7% of the portfolio.
Compared with Q3 2019, the fund opened 23 new positions and exited 34.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q4 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.3B | 36 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.3B | 35 | Feb 10, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.2B | 35 | Nov 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.2B | 35 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.1B | 32 | May 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.3B | 34 | Feb 11, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.4B | 36 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.4B | 33 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $887M | 34 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $832M | 31 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $744M | 32 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $754M | 30 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $802M | 33 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $680.5B | 46 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $545M | 51 | Nov 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $529M | 49 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $584M | 50 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $644M | 53 | Feb 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $588M | 55 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $605M | 58 | Aug 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $568M | 59 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $467M | 55 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $377M | 58 | Aug 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $275M | 60 | May 6, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $859M | 100 | Jan 30, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2019 | $424M | 92 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $432M | 108 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $628M | 108 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $589M | 105 | Feb 11, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 2 additional managers.
- M.D. Sass Associates, Inc.028-12005
- M.D. Sass, LLC028-16534
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.